Get startedLog in
    Picture of Kyverna Therapeutics logo

    KYTX — Kyverna Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Gilead-backed Kyverna Therapeutics valued at $1.4 bln in stellar debut

    Picture of Kyverna Therapeutics logoKyverna Therapeutics
    08/02/2024 18:41
    Feb 8 (Reuters) - Shares of Kyverna Therapeutics
 KYTX.O  jumped 55.7% in their market debut on Thursday, giving
the biopharmaceutical company that is backed by Gilead Sciences
 GILD.O  a market capitalization of $1.4 billion.

 (Reporting by Arasu Kannagi Basil in Bengaluru; Editing by
Shinjini Ganguli)
 ((ArasuKannagi.Basil@thomsonreuters.com;))

    Recent news on Kyverna Therapeutics

    See all news